cáncer

The report prepared by No es Sano confirms that cancer treatments are one of the groups of drugs with the highest prices and that generate the most income for the pharmaceutical industry. However, there is a significant public investment in the research phases and in the clinical trials of many of the drugs that remains invisible.

10/05/2018

Cancer drugs: high prices and inequality

The report prepared by No es Sano confirms that cancer treatments are one of the groups of drugs with the highest prices and that generate the most income for the pharmaceutical industry. […]
10/05/2018

Medicamentos para el cáncer: altos precios y desigualdad

El informe elaborado por No es Sano constata que los tratamientos para el cáncer son uno de los grupos de medicamentos con precios más altos y que más ingresos generan para la […]